RICHARD C. PFENNIGER, JR.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BioCardia, Inc.

Filing Date Source Excerpt
2018-04-27 Richard C. Pfenniger, Jr. was appointed to our board of directors in October 2016. ... Member of the compensation committee ... The following table sets forth summary information concerning the compensation awarded to, paid to, or earned by the non-employee members of our board of directors for the fiscal year ended December 31, 2017: ... Richard C. Pfenniger, Jr. ... Total ($) 258,280.00
2019-10-15 Richard C. Pfenniger, Jr. was appointed to our board of directors in October 2016. From May 2014 to February 2015, Mr. Pfenniger served as Interim Chief Executive Officer of Vein Clinics of America, Inc., a medical group specializing in the treatment of vein disease. From January 2013 to May 2013, Mr. Pfenniger served as Interim Chief Executive Officer of IntegraMed America, Inc., an operator of the largest U.S. network of fertility centers. From October 2003 until October 2011, when it was acquired by Metropolitan Health, Inc., he served as Chairman of the board of directors and President and Chief Executive Officer of Continucare Corporation, a provider of primary care physician and practice management services. Prior thereto, Mr. Pfenniger served as Chief Executive Officer of Whitman Education, Inc. from 1997 to 2003 and as Chief Operating Officer of IVAX Corporation from 1994 to 1997 after having served as the Senior Vice President – Legal Affairs from 1989 to 1994. Mr. Pfenniger currently serves as a director on the board of directors of OPKO Health, Inc., a pharmaceutical and medical diagnostic company, since 2008; on TransEnterix, Inc., a medical device company, since 2005; on GP Strategies, Inc., a corporate training and performance improvement company, since 2005; and on IntegraMed America, Inc. since 2012. Mr. Pfenniger holds a Juris Doctor degree from the University of Florida and a Bachelor of Business Administration degree from Florida Atlantic University.

OPKO HEALTH, INC.

Filing Date Source Excerpt
2017-04-28 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... The following table sets forth information provided by the nominees as of April 20, 2017. ... Richard C. Pfenniger, Jr. 61 2008 Director ... The following table sets forth information with respect to compensation of non-employee directors of the Company earned for fiscal year 2016. ... Richard C. Pfenniger, Jr. 25,000 Fees Earned, 73,600 Option Awards, Total 98,600 ... Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Dr. Krasno.
2018-04-30 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Dr. Krasno. ... Fiscal 2017 Director Compensation shows Mr. Pfenniger Fees Earned or Paid in Cash $35,000, Option Awards $74,700, Total $109,700.
2019-04-26 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Dr. Krasno. ... The following table sets forth information with respect to compensation of non-employee directors of the Company earned for fiscal year 2018. ... Richard C. Pfenniger Fees Earned or Paid in Cash 35,000, Option Awards 60,000, Total 95,000.
2020-04-29 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... Fiscal 2019 Director Compensation ... Richard C. Pfenniger, Jr. Fees Earned or Paid in Cash $35,000, Option Awards $31,500, Total $66,500. ... Committees: Audit (Chair), Succession.
2021-04-30 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Drs. Krasno and Lachman. ... Our Succession Committee is composed of Drs. Fishel, Krasno and Lerner, and Mr. Pfenniger.
2022-06-03 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... The following table shows the current members (indicated by an “X” or “Chair”) of each of our standing Board committees: ... Richard C. Pfenniger, Jr. Chair — — — Chair ... Fiscal 2021 Director Compensation ... Richard C. Pfenniger, Jr. 49,323 139,200 188,523
2023-05-01 Our Audit Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Drs. Krasno and Lachman. Our Succession Committee is composed of Messrs. Pfenniger (Chairman) and Paganelli, and Dr. Krasno.
2024-02-29 Richard C. Pfenniger, Jr., Director since 2008. Committees: Audit (Chair), Succession (Chair). Fiscal 2023 compensation: $134,800.
2025-03-14 Richard C. Pfenniger, Jr. Mr. Pfenniger is a private investor and has served as a director of the Company since January 2008. ... Mr. Pfenniger also brings financial expertise to the Board, including through his service as Chairman of our Audit Committee. ... The following table shows the current members (indicated by an “X” or “Chair”) of each of our standing Board committees: ... Richard C. Pfenniger, Jr. Audit Committee Chair, Succession Committee Chair. ... Fiscal 2024 Director Compensation: Richard C. Pfenniger, Jr. 70,000 cash fees, 49,800 stock awards, total 119,800.

Data sourced from SEC filings. Last updated: 2026-02-03